Nasal decolonization background and introduction of new alcohol based tool

Nasal decolonization of Staph aureus
Research in support of nasal decolonization

Nasal decolonization is an important topic which is covered in the whitepaper "Emerging Strategies on Achieving Nasal Decolonization for Reducing Hospital Acquired Infections" (download here). Studies show that nasal carriage plays a major role in HAI and SSI and that infection control protocols which include nasal decolonization reduced infections by 44%. Nasal decolonization is a promising opportunity for infection control and remains under-utilized. Hand to nose contact occurs about every 4 minutes on average, often compromising hand hygiene and risking contamination. 80% of SSI pathogens’ DNA can be tracked to the patient’s own nose.

On the basis of new reimbursement policies and significant recent studies, facilities and hospitals recognize the imperative of patient nasal carriage reduction programs such as Universal Decontamination (HCA Hospitals), pre-operative screen and treat, and mupirocin use prior to surgery. Research also indicates that including nasal hygiene for health care workers (HCW) can also be beneficial. For more information see "Why You Need Nasal Sanitizer®".

The Medical University of South Carolina initiated a clinical study that incorporated Nozin Nasal Sanitizer (see link at clinicaltrials.gov). The study is now complete and the results are published in the American Journal of Infection Control.

What is Nozin® Nasal Sanitizer® advanced antiseptic?

Nozin® Nasal Sanitizer® Advanced Antiseptic is a non-prescription product with demonstrated microbial killing activity that is topically applied with a swab to the skin at the opening (vestibule) of each nostril. The result of years of research, the patented Nasal Sanitizer® Nozaseptin® formula combines the safe, proven, antiseptic power of ethyl alcohol with the emollient, antioxidant benefits of natural oils and use for decolonization of the nose at the nasal vestibule. Nozin Nasal Sanitizer® is well tolerated as it has a pleasant citrus scent, is gentle and highly moisturizing to the nasal opening, while maintaining potent antimicrobial activity. Unlike an antibiotic, Nasal Sanitizer® does not promote antibiotic resistance as it utilizes non-selective antiseptic action of ethanol.

As mentioned, this product is applied to the nasal vestibule, a critical site where pathogens, such as S. aureus, colonize. After colonization pathogens can be transmitted, often by hand to nose contact, to others or to the skin where they can cause infections. Decolonization with Nozin Nasal Sanitizer® decreases nasal bacteria carriage, helps maintain hand hygiene by lowering chance of nose to hand transmission and can help reduce the risk of infections.

In testing by independent FDA registered laboratories, Nasal Sanitizer® was shown on application in vitro to kill 99.99% of a broad spectrum of pathogenic organisms. Clinical studies show the product reduces harmful germs for up to 8 hours. Nozin Nasal Sanitizer® has also been shown to decrease Staph aureus and other nasal bacteria carriage. To learn more product information, ingredients and how to apply with the Popswab® ampule click here.

Nasal Decolonization with Nozin® Nasal Sanitizer®

Nozin® Nasal Sanitizer® can be used throughout your healthcare facility and hospital as an integral part of infection control for nasal decolonization, enhance hand hygiene efforts and lower the risk of nasal pathogen transmission. A comprehensive implementation could include:

  • Patient use
    • high risk areas such as Emergency Room and ICU
    • pre and post procedure measures
    • facility/hospital-wide
  • Staff use
    • high risk areas such as Emergency Room and ICU
    • facility/hospital-wide
  • Visitors use
    • facility/high risk areas

Learn about the 360™ Program and nasal decolonization solutions for your facility.

Published, peer-reviewed research on Nozin® Nasal Sanitizer®

The American Journal of Infection Control (AJIC) has published the article: “Reduction of nasal Staphylococcus aureus carriage in health care professionals by treatment with a nonantibiotic, alcohol-based nasal antiseptic”

Here's a link to AJIC website for the article on the clinical study which showed that Nozin® Nasal Sanitizer® antiseptic was effective in reducing Staph aureus and total bacterial carriage, ”suggesting the usefulness of this approach as a safe, effective and convenient alternative to antibiotic treatment.”

Here's a link to a related post on Nozin professional site.

Implement Nozin in your facility.

The Nozin Team will fully support facilities as they go through the implementation process and assist in creating high-impact clinical nasal decolonization protocols for Nasal Sanitizer®.
Learn about the 360™ Program and nasal decolonization solutions for your facility.

The Facts

Have a Question?
We can help.


Private, secure, spam-free.


Health Professionals:
Request Nozin® samples for your facility.
© 2004-2017 Global Life Technologies Corp. All rights reserved. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease.